MET:NYSEMetLife, Inc. Analysis

MetLife (MET) is trading at $81.08, well below its DCF-derived fair value of $212.18, implying a material valuation gap. The stock’s forward PE of 7.38 versus a trailing PE of 15.68 signals strong earnings upside expectations, reinforced by a Q1 earnings beat and a 10% rise in net investment income. Revenue growth remains modest at 2.7% but operating margins are stable around 9.9%, and the dividend yield of 2.91% with a payout ratio under 45% supports income‑focused investors. Technicals show the price above the 20‑day and 50‑day SMAs (78.90 and 74.63), yet RSI at 65 and a bearish MACD histogram suggest short‑term overbought pressure. Volatility over the past 30 days sits near 21% with a beta around 1.0, indicating market‑level risk, while the sector’s regulatory environment adds a moderate layer of uncertainty. Overall, the combination of a sizable valuation discount, solid dividend sustainability, and positive earnings momentum makes MET an attractive candidate for medium‑ to long‑term accumulation.